StockDriftsStockDriftsTop 1 Kinnevik Ab (Publ) Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals, Inc. | 100% | 13.43M | $65.6M | +0.00%(+0) | $8.88(-52.13%) | 2025-09-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative | Since First Filing (12 quarters) |
|---|---|---|---|---|---|
| Top 20 Holdings Weighted | -25.07% | -57.93% | — | — | -57.93% |
| Top 20 Holdings Unweighted | -36.00% | -73.79% | — | — | -73.79% |
Kinnevik Ab (Publ) reports $65.56M in US-listed equity holdings across 1 position in its most recent 13F filing. Its largest disclosed position is RXRX (100.0%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned -57.93% on a three-year cumulative basis. Figures reflect the Q3 2025 filing.
Sign up free to track Kinnevik Ab (Publ), compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Kinnevik Ab (Publ)’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1766574). View Kinnevik Ab (Publ)’s 13F filings on SEC